medRxiv preprint doi: https://doi.org/10.1101/2020.06.15.20130989; this version posted June 16, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

Predictive Accuracy of a Hierarchical Logistic Model of Cumulative
SARS-CoV-2 Case Growth
Levente Kriston1
1

Department of Medical Psychology, University Medical Center Hamburg-Eppendorf, Martinistr. 52,
D-20246 Hamburg, Germany, E-mail: l.kriston@uke.de, Tel: +49 (0)40 7410 56849

ABSTRACT
Background: Infectious disease predictions models, including virtually all epidemiological models
describing the spread of the SARS-CoV-2 pandemic up to June 2020, are rarely evaluated. The aim of
the present study was to investigate the predictive accuracy of a prognostic model for forecasting the
development of the cumulative number of reported SARS-CoV-2 cases in countries and administrative
regions worldwide.
Methods: The cumulative number of reported SARS-CoV-2 cases was forecasted in 251 regions with a
horizon of two weeks, one month, and two months using a previously described hierarchical logistic
model at the end of March 2020. Forecasts were compared to actual observations by using a series of
evaluation metrics.
Results: On average, predictive accuracy was very high in nearly all regions at the two weeks forecast,
high in most regions at the one month forecast, and notable in the majority of the regions at the two
months forecast. Higher accuracy was associated with the availability of more data for estimation and
with a more pronounced cumulative case growth from the first case to the date of estimation. In some
strongly affected regions, cumulative case counts were considerably underestimated.
Conclusions: With keeping its limitations in mind, the investigated model can be used for the
preparation and distribution of resources during the SARS-CoV-2 pandemic. Future research should
primarily address the modelâ€™s assumptions and its scope of applicability. In addition, establishing a
relationship with known mechanisms and traditional epidemiological models of disease transmission
would be desirable.

Keywords: COVID-19, coronavirus, communicable diseases, epidemiologic methods, forecasting,
statistical models, public health
Acknowledgments: The study was not externally funded.
Conflict of interest: The author reports no conflict of interest.
Data availability: The analyzed data are publicly available.

NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice.

1

medRxiv preprint doi: https://doi.org/10.1101/2020.06.15.20130989; this version posted June 16, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

BACKGROUND
Mathematical and simulation models of infectious disease dynamics are essential for understanding
and forecasting the development of epidemics.1 As of June 2020, the ongoing severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) pandemic has called increased attention to epidemiological
modeling both as a method of scientific inquiry and as a tool to inform political decision making.2â€“5
Among epidemiological modeling methods, a distinction between mechanistic and phenomenological
approaches is frequently made. While mechanistic approaches model the transmission dynamics
based on substantial concepts from biology, virology, infectology, and related disciplines,
phenomenological (sometimes termed â€˜statisticalâ€™) models are looking for a mathematical function
that fits observed data well without clear assumptions about the underlying processes.1,2 Mechanistic
models are usually used to compare possible scenarios and to estimate the relative effects of different
interventions rather than to produce precise predictions. On the contrary, phenomenological models
are commonly optimized for forecasting. From a broader perspective, mechanistic and
phenomenological approaches can be considered as the epidemiological modeling representatives of
the long-standing explanation-prediction controversy.6 It should be noted that although the distinction
between these two model classes is instructive and one side usually predominates, most approaches
have both mechanistic and phenomenological components, and some are explicitly balanced (so called
â€˜semi-mechanisticâ€™ or â€˜hybridâ€™ models).
Although the value of any predictive model is ultimately determined by whether it improved critical
decision making,7,8 a rigorous scientific appraisal should also include a comparison of what have been
predicted to what have actually happened.1,9,10 Unfortunately, infectious disease predictions models
are rarely evaluated during or after outbreaks.9,10 Notable exceptions include systematic evaluation of
models about the epidemiology of severe acute respiratory syndrome (SARS),11,12 influenza,13,14
ebola,7,9,15,16 dengue,10,17 foot-and-mouth disease,8 and trachoma.18
The SARS-CoV-2 pandemic has prompted a large amount of epidemiological modeling efforts, including
studies with primarily mechanistic (e.g., references19â€“25), primarily phenomenological (e.g.,
references26â€“29), and hybrid (e.g., reference30) approaches. According to the knowledge of the author
up to June 2020, none of the existing models was systematically evaluated with regard to the accuracy
of their predictions. In order to start closing this gap, the objective of the present study was to evaluate
the predictive accuracy of a phenomenologically oriented model that was trained on data up to the
end of March 2020 for forecasting the development of the cumulative number of reported SARS-CoV2 cases in countries and administrative regions worldwide.31

METHODS
Data
As described in detail elsewhere,31 the model was fitted using information on the cumulative number
of confirmed SARS-CoV-2 infections in the COVID-19 data repository of the Johns Hopkins University
Center for Systems Science and Engineering.32,33 Cumulative case count data from 251 countries and
administrative regions were used for training the model, with daily time series from the day of the first
reported case to 29 March 2020 in each region. For evaluation, data of confirmed cases were extracted
from the same database two weeks, one month, and two months after model development (12 April,
29 April, and 29 May 2020). Sufficient information for creating predictions of the most likely number
2

medRxiv preprint doi: https://doi.org/10.1101/2020.06.15.20130989; this version posted June 16, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

of cases in all investigated countries and administrative regions for any time horizon was made publicly
available at the beginning of April 2020.31

Model
A hierarchical logistic model was fit to observed data.31 The logistic part of the model was based on
the ecological concept of self-limiting population growth34 and used a formulation with five
parameters35 controlling the expected final case count at the end of the outbreak (parameter a), the
maximum speed of reaching the expected final case count (parameter b), the approximate time point
of the transition of the outbreak from an accelerating to a decelerating dynamic (parameter c), the
case count at the beginning of the outbreak (parameter d), and the degree of asymmetry between the
accelerating and decelerating phases of the outbreak (parameter g). The predicted number of
cumulative case counts in region i at day t from the first reported case was estimated as
ğ‘›ğ‘ğ‘Ÿğ‘’ğ‘‘,ğ‘–ğ‘¡ = ğ‘‘ğ‘– +

ğ‘ğ‘– âˆ’ ğ‘‘ğ‘–
ğ‘¡ ğ‘ğ‘–
(1 + (ğ‘ ) )

ğ‘”ğ‘–

ğ‘–

with log-normally distributed errors.
The hierarchical part of the model was inspired by random-effect meta-analysis assuming that the
parameters of the logistic equation are similar, but not necessarily identical, across the investigated
regions.36,37 This was implemented by restricting the parameters of the logistic equation to follow a
normal distribution in the population of regions. With respect to interpretation, this means that the
model was based on the hypothesis that the pandemic runs a similar course in all countries and
regions, even though they are expected to differ to a certain degree regarding the number of cases in
their first report, the expected final case count, the time point and speed of the accelerating and
decelerating phases of the outbreak, as well as the time point, extent, and effects of control measures.

Evaluation metrics
For evaluating each individual estimate i at time point t, four measures were calculated.
The difference between logarithmic predicted and observed counts (â€œerror in logsâ€, EIL) was defined
as
ğ¸ğ¼ğ¿ğ‘–ğ‘¡ = ln ğ‘›ğ‘ğ‘Ÿğ‘’ğ‘‘,ğ‘–ğ‘¡ âˆ’ ln ğ‘›ğ‘œğ‘ğ‘ ,ğ‘–ğ‘¡ ,
with ln being the natural logarithm, and npred and nobs being the predicted and the observed cumulative
case counts, respectively.
The absolute error in logs (AIEL) was calculated as
ğ´ğ¸ğ¼ğ¿ğ‘–ğ‘¡ = |ln ğ‘›ğ‘ğ‘Ÿğ‘’ğ‘‘,ğ‘–ğ‘¡ âˆ’ ln ğ‘›ğ‘œğ‘ğ‘ ,ğ‘–ğ‘¡ | .

The percentage error (PE) was calculated as

3

medRxiv preprint doi: https://doi.org/10.1101/2020.06.15.20130989; this version posted June 16, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

ğ‘ƒğ¸ğ‘–ğ‘¡ =

ğ‘›ğ‘ğ‘Ÿğ‘’ğ‘‘,ğ‘–ğ‘¡ âˆ’ ğ‘›ğ‘œğ‘ğ‘ ,ğ‘–ğ‘¡
,
ğ‘›ğ‘œğ‘ğ‘ ,ğ‘–ğ‘¡

and the absolute percentage error (APE) as
ğ´ğ‘ƒğ¸ğ‘–ğ‘¡ =

|ğ‘›ğ‘ğ‘Ÿğ‘’ğ‘‘,ğ‘–ğ‘¡ âˆ’ ğ‘›ğ‘œğ‘ğ‘ ,ğ‘–ğ‘¡ |
.
ğ‘›ğ‘œğ‘ğ‘ ,ğ‘–ğ‘¡

Summary estimates of predictive accuracy across all k regions at a given time point t are listed in the
following.
The root mean squared error in logs (RMSE) was defined as
ğ‘˜
2

ğ‘…ğ‘€ğ‘†ğ¸ğ‘¡ = âˆšâˆ‘(ln ğ‘›ğ‘ğ‘Ÿğ‘’ğ‘‘,ğ‘–ğ‘¡ âˆ’ ln ğ‘›ğ‘œğ‘ğ‘ ,ğ‘–ğ‘¡ ) ,
ğ‘–=1

and the mean absolute percentage error (MAPE) was calculated as
âˆ‘ğ‘˜ğ‘–=1
ğ‘€ğ´ğ‘ƒğ¸ğ‘¡ =

|ğ‘›ğ‘ğ‘Ÿğ‘’ğ‘‘,ğ‘–ğ‘¡ âˆ’ ğ‘›ğ‘œğ‘ğ‘ ,ğ‘–ğ‘¡ |
ğ‘›ğ‘œğ‘ğ‘ ,ğ‘–ğ‘¡
.
ğ‘˜

The coefficient of determination R2t was additionally determined from a linear model regressing the
logarithmic observed values on the logarithmic predictions with the intercept fixed at zero.
Furthermore, the intraclass correlation coefficient ICC(3,1)t was calculated for quantifying the level of
absolute agreement between predicted and observed values from a two-way mixed-effects model.38
Bootstrapping was used with 1,000 samples to create 95% confidence intervals for summary estimates
of predictive accuracy.

Factors associated with accuracy
In order to identify factors associated with the accuracy of the predictions, the AEIL was regressed on
the number of available data points, the difference in the logarithm of the first and the last case count
at the moment of estimation (as a proxy for progress of the epidemic), and their interaction term.
Estimates are reported with 95% parametric confidence intervals.
Furthermore, strongly affected regions (defined by a minimum of 10,000 cases at the forecasted time
point) with the most extreme under- and overestimation were identified to gain additional qualitative
insights on model performance.

RESULTS
Data
In 251 regions, the number of available data points at estimation ranged from 2 to 68 with a median
of 25 and a mean of 31.48 days. The cumulative number of reported cases at the point of the first nonzero count ranged from 1 to 444 with a median of 1 and a mean of 4.09 across regions. The cumulative

4

medRxiv preprint doi: https://doi.org/10.1101/2020.06.15.20130989; this version posted June 16, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

number of reported cases at model estimation (29 March 2020) ranged from 1 to 140,886 with a
median of 139 and a mean of 2,869.

Individual estimates of predictive accuracy
The probability density function of the percentage error (PE) at the day of estimation as well at the
forecasts after two weeks, one month, and two months, respectively, is displayed in Figure 1. At the
day of estimation, the median relative error indicated an average underestimation of the cumulative
case count by about one third across regions. The relative error distribution was rather narrow, with
only a tenth of predictions showing an underestimation exceeding -62.8 percent and none of the
predictions having more than 36.9 percent error. Across forecasts, the median percentage error was
always less than twenty percent, although an overestimation by more than two hundred percent was
observed in 7.2, 19.1, and 19.5 percent of the cases at the two weeks, one months, and two months
forecasts, respectively. The proportion of regions with an underestimation exceeding minus two thirds
(-66.6 percent) was 12.4, 19.5, and 28.7 percent at the two weeks, one months, and two months
forecasts, respectively.

Figure 1. Probability density function of the percentage error at different forecast horizons
The solid line shows the median, the dashed lines show the first and third quartiles, and the dotted lines show the first and
ninth deciles. The x-axis is trimmed at 2.5.

5

medRxiv preprint doi: https://doi.org/10.1101/2020.06.15.20130989; this version posted June 16, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

The calibration plots suggest an increasing number of regions for which case counts are substantially
under- or overestimated with increasing length of the forecast period (Figure 2). Nevertheless, a
strong positive association between predicted and observed case counts is apparent even after two
months.

Figure 2. Calibration plots at different forecast horizons
Points refer to regions. The solid black line indicates no prediction error, the blue area indicates a prediction error by a factor
of two or less, and the green area indicates a prediction error by a factor of ten or less. Both axes are log-transformed.

Summary estimates of predictive accuracy
All parameters show an increasing amount of error with increasing length of the forecast period
(Table 1). The MAPE shows that, on average, estimates are off by more than one hundred, two
hundred, and four hundred percent at the two weeks, one month, and two months forecasts,
respectively. The coefficient of determination indicates a very strong relative association between
predicted and observed case counts, and the intraclass correlation coefficient suggests that the level
of absolute agreement is excellent after two weeks and still high after one month, but sinks to a
moderate level after two months.

6

medRxiv preprint doi: https://doi.org/10.1101/2020.06.15.20130989; this version posted June 16, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

Table 1. Summary estimates of predictive accuracy
RMSE
(95% CI)

MAPE
(95% CI)

R2
(95% CI)

ICC
(95% CI)

Day of estimation

0.640
(0.577 to 0.707)

0.323
(0.295 to 0.356)

0.989
(0.986 to 0.992)

0.984
(0.979 to 988)

Two weeks forecast

0.900
(0.803 to 1.05)

1.085
(0.673 to 2.598)

0.980
(0.971 to 0.984)

0.935
(0.905 to 0.950)

One month forecast

1.393
(1.271 to 1.546)

2.133
(1.600 to 2.953)

0.958
(0.948 to 0.966)

0.828
(0.777 to 0.866)

Two months forecast

1.958
(1.791 to 2.157)

4.250
(2.907 to 6.735)

0.931
(0.914 to 0.943)

0.679
(0.606 to 0.748)

RMSE=root mean squared error in logarithmic case counts; MAPE=mean absolute percentage error in case counts;
R2=coefficient of determination; ICC=intraclass correlation; CI=confidence interval

Factors associated with accuracy
Visual analysis suggests that a larger number of available data points at estimation (Figure 3) and a
more extensive growth of the logarithmic case counts from the first reported case until estimation
(Figure 4) are associated with a lower prediction error.

Figure 3. Association of the amount of available data at estimation and predictive accuracy (AEIL) at
different forecast horizons
AEIL= absolute difference between logarithmic predicted and observed case counts. Points refer to regions. The grey line
corresponds to a linear smoothing curve.
7

medRxiv preprint doi: https://doi.org/10.1101/2020.06.15.20130989; this version posted June 16, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

This is confirmed by regression analyses indicating statistically significant associations that are
becoming stronger with increasing forecast horizon (Table 2). These two factors have also a
multiplicative effect, as indicated by the statistically significant interaction term.

Figure 4. Association of growth in logarithmic case counts until estimation and predictive accuracy
(AEIL) at different forecast horizons
AEIL= absolute difference between logarithmic predicted and observed case counts. Points refer to regions. The grey line
corresponds to a linear smoothing curve.

Table 2. Regression coefficients for factors associated with prediction accuracy (AEIL)
Number of data points in
weeks
(95% CI)

Growth in logarithmic case
counts until estimation
(95% CI)

Interaction
term
(95% CI)

Day of estimation

-0.077***
(-0.114 to -0.040)

-0.016
(-0.055 to 0.023)

0.002
(-0.005 to 0.009)

Two weeks forecast

-0.073*
(-1.304 to -0.015)

-0.100**
(-1.614 to -0.039)

0.011*
(0.000 to 0.022)

One month forecast

-0.131**
(-0.216 to -0.046)

-0.145**
(-0.235 to -0.054)

0.017*
(0.001 to 0.034)

Two months forecast

-0.242***
(-0.361 to -0.124)

-0.242***
(-0.368 to -0.117)

0.032**
(0.010 to 0.055)

AEIL= absolute difference between logarithmic predicted and observed case counts; CI=confidence interval; *p<.050;
**p<.010; ***p<.001
8

medRxiv preprint doi: https://doi.org/10.1101/2020.06.15.20130989; this version posted June 16, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

Strongly affected regions (a minimum of 10,000 cases) with extreme under- or overestimation of the
cumulative case counts are presented in Table 4. Among the listed regions, the extent of
underestimation was considerable (an EIL below -1.6, roughly corresponding to an underestimation by
a factor of five) at the one and two months forecasts, with most regions being located in Asia. Among
strongly affected regions, overestimation was rather moderate (an EIL below 0.7, roughly
corresponding to an overestimation by a factor of two) in most cases. Substantial overestimation (an
EIL between 0.7 and 1.6) was present in Austria and Switzerland at the one and two months forecasts
and in the United States at the one month forecast. No strongly affected region with a considerable
overestimation (EIL above 1.6) was identified.
Table 3. Most extreme under- or overestimation for regions with a minimum number of 10,000
cases
Underestimation

Day of estimation

Two weeks forecast

One month forecast

Two months forecast

Overestimation

Region

EIL

Region

EIL

Belgium

-0.565

Hubei, China

0.022

United States of America

-0.444

Germany

0.020

Netherlands

-0.422

NA

NA

Switzerland

-0.322

NA

NA

Italy

-0.301

NA

NA

Belgium

-1.274

Austria

0.657

Sweden

-1.171

Quebec, Canada

0.498

Russia

-0.939

Switzerland

0.399

France

-0.651

United States of America

0.336

Iran

-0.556

Germany

0.096

Belarus

-3.719

Austria

1.281

Qatar

-3.159

Switzerland

0.889

Singapore

-3.155

United States of America

0.714

India

-2.301

Quebec, Canada

0.638

Russia

-2.290

Portugal

0.402

Bangladesh

-6.097

Austria

1.398

Belarus

-4.730

Switzerland

1.012

Qatar

-4.597

United States of America

0.399

Kuwait

-4.104

Israel

0.358

India

-3.864

Portugal

0.302

EIL= difference between logarithmic predicted and observed case counts; NA=not applicable

DISCUSSION
In the present study, a hierarchical logistic model was used to predict cumulative counts of confirmed
SARS-CoV-2 cases in 251 countries and administrative regions with two weeks, one month, and two
months forecasting horizons. Several metrics were used to evaluate predictions visually and
statistically. In summary, case counts could be predicted in the majority of the regions with a surprising
accuracy. In spite of the facts that at the time of estimation (29 March 2020) only about one monthâ€™s
data were available on average in each region, and that most regions were at the very beginning of the
epidemic, a massive difference between forecast and observation was rather the exception than the
9

medRxiv preprint doi: https://doi.org/10.1101/2020.06.15.20130989; this version posted June 16, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

rule. Summary metrics of predictive accuracy suggested very strong prognostic validity the model for
a horizon of two weeks, substantial accuracy after one month, and still notable, although markedly
lower, accuracy after two months. This is in good agreement with studies finding that the horizon for
reasonable epidemiological predictions covers a few weeks at most.9,17
Although most predictions were fairly accurate, some were still considerably off. They were most likely
to be found in regions with a lower amount of available data at the date of estimation and/or with a
more limited growth between the date of the first case and the date of estimation. In general,
underestimation seems to be somewhat more pronounced than overestimation, particularly in
strongly affected regions (i.e., with cumulative case counts above 10,000 at the point of validation).
The strongly affected regions for which the model provided too low predictions included several
countries in which mitigation strategies might have been less effective than in other regions, as
suggested by the only slowly or not at all decelerating cumulative case growth curves at the beginning
of June 2020 (e.g., India, Bangladesh, Qatar). On the other hand, the strongly affected regions with a
substantial overestimation of cumulative case counts are characterized with an extremely successful
mitigation of the epidemic (mainly Austria and Switzerland). Hence, predictive errors are likely to be
closely related to one of the central assumptions of the model, i.e., that timing, extent, and
effectiveness of control measures is comparable across regions. Obviously, the forecasts based on the
presented model are likely to reach their limits in regions that deviate too strongly from the average
case. As shifting individual estimates towards the group mean is also a statistical property of
hierarchical models,39 extreme cases are likely to fall outside the scope of validity of the presented
approach.
A notable feature of the model that it provides predictions without any reference to measures taken
to control the epidemic. This â€œignoranceâ€ towards interventions, paired with fairly accurate
predictions, may be misinterpreted as evidence of dispensability of the mitigation and containment
measures implemented in most countries. However, it is far more likely that the key model assumption
suggesting similarity of the course of the epidemic and of the control measures taken across regions
holds to a substantial extent. In cases when it does not, model performance is very poor, as discussed
above. Bringing these issue together, the hierarchical structure of the model appears to have both
benefits and risks: sufficiently accurate predictions for a large number of regions even at a very early
stage of the epidemic come with the price of considerably erroneous predictions for atypical regions.
Consequently, if used with the aim of generating locally applicable predictions for a particular region,
forecasts may be improved by using data from comparable regions with a higher probability than from
rather dissimilar regions.40
The presented evaluation study has several limitations. First, the case counts were not standardized in
any form. Expressing them as cumulative incidence rates (e.g., per 100,000 persons) is likely to have
increased homogeneity across regions and enhanced interpretability. As it has been shown in a specific
analysis of the development of the SARS-CoV-2 epidemic in German federal states, standardization has
rendered using log-transformation of case counts for homogenization superfluous and allowed
estimating models with normally distributed errors.41 Second, in the present study uncertainty of the
predictions remained unconsidered, although measures of uncertainty, such as reliability and
sharpness, can be just as important for forecasting as bias.9 Third, predictions only at selected time
points were analyzed, and it cannot be excluded that choosing other time points would have led to
different results. Nevertheless, the general pattern of findings is unlikely to have changed substantially.
10

medRxiv preprint doi: https://doi.org/10.1101/2020.06.15.20130989; this version posted June 16, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

The forecasting model itself has some weaknesses as well.31,41 Most importantly, it models the
reported rather than the true number of cases and therefore can be subject to different forms of
testing and reporting bias. Considerable improvement regarding this point can realistically be expected
first when regional findings form well-conducted epidemiological studies become available. Another
major limitation of the model is that it works only as long as the conditions of the epidemic remain
largely unchanged in each region, i.e., within a single epidemic wave with fairly constant testing and
reporting practices and without serious disruptions. This issue could perhaps be addressed by using
dynamic (time-dependent) rather than fixed (time-invariant) model parameters.42 Finally, the primarily
phenomenological nature of the model calls for integration with mechanistic components, in order to
create a hybrid approach that is capable of producing widely generalizable conclusions.43
As stated by one of the most prominent epidemiologist of the SARS-CoV-2 pandemic, Neil Ferguson,
models are â€œnot crystal ballsâ€.3 However, without rigorous scientific evaluation, they run the risk of
becoming one, characterized not by correct predictions but by obscurity. Some state that
epidemiological forecasting is â€œmore challenging than weather forecastingâ€,44 and complexity of
modelling and reliance on assumptions make it difficult to assess the trustworthiness of models based
solely on their inherent structure. Just like we trust weather forecasts that prove to be accurate by
experience, empirical comparison of modeling predictions with actual observations should become an
essential step of epidemiological model evaluation.

REFERENCES
1. Heesterbeek H, Anderson RM, Andreasen V, et al. Modeling infectious disease dynamics in the
complex landscape of global health. Science. 2015;347(6227):aaa4339.
doi:10.1126/science.aaa4339
2. Holmdahl I, Buckee C. Wrong but useful - what Covid-19 epidemiologic models can and cannot
tell us. N Engl J Med. Published online May 15, 2020. doi:10.1056/NEJMp2016822
3. Adam D. Special report: the simulations driving the worldâ€™s response to COVID-19. Nature.
2020;580(7803):316-318. doi:10.1038/d41586-020-01003-6
4. Jewell NP, Lewnard JA, Jewell BL. Predictive mathematical models of the COVID-19 pandemic:
underlying principles and value of projections. JAMA. 2020;323(19):1893-1894.
doi:10.1001/jama.2020.6585
5. Sridhar D, Majumder MS. Modelling the pandemic. BMJ. 2020;369:m1567.
doi:10.1136/bmj.m1567
6. Shmueli G. To explain or to predict? Statist Sci. 2010;25(3):289-310. doi:10.1214/10-STS330
7. Li S-L, BjÃ¸rnstad ON, Ferrari MJ, et al. Essential information: uncertainty and optimal control of
Ebola outbreaks. PNAS. 2017;114(22):5659-5664. doi:10.1073/pnas.1617482114
8. Probert WJM, Jewell CP, Werkman M, et al. Real-time decision-making during emergency disease
outbreaks. PLoS Comput Biol. 2018;14(7):e1006202. doi:10.1371/journal.pcbi.1006202
9. Funk S, Camacho A, Kucharski AJ, Lowe R, Eggo RM, Edmunds WJ. Assessing the performance of
real-time epidemic forecasts: a case study of Ebola in the Western Area region of Sierra Leone,
2014-15. PLoS Comput Biol. 2019;15(2):e1006785. doi:10.1371/journal.pcbi.1006785
11

medRxiv preprint doi: https://doi.org/10.1101/2020.06.15.20130989; this version posted June 16, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

10. Johansson MA, Reich NG, Hota A, Brownstein JS, Santillana M. Evaluating the performance of
infectious disease forecasts: a comparison of climate-driven and seasonal dengue forecasts for
Mexico. Sci Rep. 2016;6:33707. doi:10.1038/srep33707
11. Hsieh Y-H, Cheng Y-S. Real-time forecast of multiphase outbreak. Emerg Infect Dis.
2006;12(1):122-127. doi:10.3201/eid1201.050396
12. Zhou G, Yan G. Severe acute respiratory syndrome epidemic in Asia. Emerg Infect Dis.
2003;9(12):1608-1610. doi:10.3201/eid0912.030382
13. Biggerstaff M, Alper D, Dredze M, et al. Results from the centers for disease control and
preventionâ€™s predict the 2013â€“2014 Influenza Season Challenge. BMC Infect Dis. 2016;16:357.
doi:10.1186/s12879-016-1669-x
14. Hsieh Y-H, Fisman DN, Wu J. On epidemic modeling in real time: an application to the 2009 Novel
A (H1N1) influenza outbreak in Canada. BMC Res Notes. 2010;3:283. doi:10.1186/1756-0500-3283
15. Chowell G, Viboud C, Simonsen L, Merler S, Vespignani A. Perspectives on model forecasts of the
2014â€“2015 Ebola epidemic in West Africa: lessons and the way forward. BMC Medicine.
2017;15(1):42. doi:10.1186/s12916-017-0811-y
16. Pell B, Kuang Y, Viboud C, Chowell G. Using phenomenological models for forecasting the 2015
Ebola challenge. Epidemics. 2018;22:62-70. doi:10.1016/j.epidem.2016.11.002
17. Reich NG, Lauer SA, Sakrejda K, et al. Challenges in real-time prediction of infectious disease: a
case study of dengue in Thailand. PLoS Negl Trop Dis. 2016;10(6):e0004761.
doi:10.1371/journal.pntd.0004761
18. Liu F, Porco TC, Amza A, et al. Short-term forecasting of the prevalence of trachoma: expert
opinion, statistical regression, versus transmission models. PLoS Negl Trop Dis.
2015;9(8):e0004000. doi:10.1371/journal.pntd.0004000
19. Ferguson N, Laydon D, Nedjati Gilani G, et al. Impact of non-pharmaceutical interventions (NPIs)
to reduce COVID19 mortality and healthcare demand. doi:10.25561/77482
20. Hellewell J, Abbott S, Gimma A, et al. Feasibility of controlling COVID-19 outbreaks by isolation of
cases and contacts. Lancet Glob Health. 2020;8(4):e488-e496. doi:10.1016/S2214109X(20)30074-7
21. Kucharski AJ, Russell TW, Diamond C, et al. Early dynamics of transmission and control of COVID19: a mathematical modelling study. Lancet Infect Dis. 2020;20:553-558. doi:10.1016/S14733099(20)30144-4
22. Wu JT, Leung K, Leung GM. Nowcasting and forecasting the potential domestic and international
spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. Lancet.
2020;395(10225):689-697. doi:10.1016/S0140-6736(20)30260-9
23. Koo JR, Cook AR, Park M, et al. Interventions to mitigate early spread of SARS-CoV-2 in
Singapore: a modelling study. Lancet Infect Dis. 2020;20(6):678-688. doi:10.1016/S14733099(20)30162-6

12

medRxiv preprint doi: https://doi.org/10.1101/2020.06.15.20130989; this version posted June 16, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

24. Dehning J, Zierenberg J, Spitzner FP, et al. Inferring change points in the spread of COVID-19
reveals the effectiveness of interventions. Science. Published online May 15, 2020.
doi:10.1126/science.abb9789
25. Maier BF, Brockmann D. Effective containment explains subexponential growth in recent
confirmed COVID-19 cases in China. Science. 2020;368(6492):742-746.
doi:10.1126/science.abb4557
26. Roosa K, Lee Y, Luo R, et al. Real-time forecasts of the COVID-19 epidemic in China from February
5th to February 24th, 2020. Infect Dis Model. 2020;5:256-263. doi:10.1016/j.idm.2020.02.002
27. Roosa K, Lee Y, Luo R, et al. Short-term Forecasts of the COVID-19 Epidemic in Guangdong and
Zhejiang, China: February 13-23, 2020. J Clin Med. 2020;9(2):596. doi:10.3390/jcm9020596
28. IHME COVID-19 health service utilization forecasting team, Murray CJ. Forecasting COVID-19
impact on hospital bed-days, ICU-days, ventilator-days and deaths by US state in the next 4
months. medRxiv. Published online March 30, 2020. doi:10.1101/2020.03.27.20043752
29. IHME COVID-19 health service utilization forecasting team, Murray CJ. Forecasting the impact of
the first wave of the COVID-19 pandemic on hospital demand and deaths for the USA and
European Economic Area countries. medRxiv. Published online April 26, 2020.
doi:10.1101/2020.04.21.20074732
30. Flaxman S, Mishra S, Gandy A, et al. Estimating the number of infections and the impact of nonpharmaceutical interventions on COVID-19 in 11 European countries. 35. doi:10.25561/77731
31. Kriston L. Projection of cumulative coronavirus disease 2019 (COVID-19) case growth with a
hierarchical logistic model. Bull World Health Organ COVID-19 Open Preprints. Published online
April 7, 2020. doi:http://dx.doi.org/10.2471/BLT.20.257386
32. Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time.
Lancet Infect Dis. 2020;in press. doi:10.1016/S1473-3099(20)30120-1
33. Johns Hopkins University Center for Systems Science and Engineering. 2019 Novel Coronavirus
COVID-19 (2019-nCoV) Data Repository. Published 2020. Accessed June 1, 2020.
https://github.com/CSSEGISandData/COVID-19
34. Kingsland S. The refractory model: the logistic curve and the history of population ecology. Q Rev
Biol. 1982;57(1):29-52. doi:10.1086/412574
35. Gottschalk PG, Dunn JR. The five-parameter logistic: a characterization and comparison with the
four-parameter logistic. Anal Biochem. 2005;343(1):54-65. doi:10.1016/j.ab.2005.04.035
36. Riley RD, Higgins JPT, Deeks JJ. Interpretation of random effects meta-analyses. BMJ.
2011;342:d549-d549. doi:10.1136/bmj.d549
37. Kriston L. Dealing with clinical heterogeneity in meta-analysis. Assumptions, methods,
interpretation. Int J Meth Psych Res. 2013;22(1):1-15. doi:10.1002/mpr.1377
38. Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull.
1979;86(2):420-428.
39. Diez R. A glossary for multilevel analysis. J Epidemiol Community Health. 2002;56(8):588-594.
doi:10.1136/jech.56.8.588
13

medRxiv preprint doi: https://doi.org/10.1101/2020.06.15.20130989; this version posted June 16, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

40. Kriston L, Meister R. Incorporating uncertainty regarding applicability of evidence from metaanalyses into clinical decision making. J Clin Epidemiol. 2014;67(3):325-334.
doi:10.1016/j.jclinepi.2013.09.010
41. Kriston L. Aktuelle Entwicklung der kumulativen Inzidenz bestÃ¤tigter SARS-CoV-2-Infektionen und
infektionsbedingter TodesfÃ¤lle in Deutschland. [Modeling the cumulative incidence of SARS-CoV2 cases and deaths in Germany]. [German]. OSF Preprints. Published online May 5, 2020.
doi:10.31219/osf.io/q2yw5
42. Scarpino SV, Petri G. On the predictability of infectious disease outbreaks. Nature Commun.
2019;10:898. doi:10.1038/s41467-019-08616-0
43. Kriston L. Machine learningâ€™s feet of clay. J Eval Clin Pract. 2020;26(1):373-375.
doi:10.1111/jep.13191
44. Moran KR, Fairchild G, Generous N, et al. Epidemic forecasting is messier than weather
forecasting: the role of human behavior and internet data streams in epidemic forecast. J Infect
Dis. 2016;214(Suppl 4):S404-S408. doi:10.1093/infdis/jiw375

14

